breast cancer. Malignant neoplasm of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Breast cancer patients that are candidates for neoadjuvant chemotherapy Underwenting previous chemotherapy for any reason or candidate for current chemotherapy due to lymph node Involvement Involvement of lymph nodes confirmed by pathology. Involvement of lymph nodes ( N1 or N2a)
Exclusion criteria
Exclusion criteria: Extensive lymph node ( N2b or N30) or skin involvement Failure to follow the treatment by the patient after the intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Finding the involved lymph nodes after neoadjuvant chemotherapy. Timepoint: Indian ink injection the day before surgery and the morning of surgery in one group and also before the beginning of of neoadjuvant chemotherapy in the other group. Method of measurement: details of the lymph nodes will be written on the relevant container after the excision and will be examined by an experienced pathologist, and finally the desired variables will be entered directly in the Data Sheet of SPSS program. | — |
Secondary
| Measure | Time frame |
|---|---|
| Success in injecting Indian ink, success in injecting methylene blue , succeeding in finding lymph nodes stained with Indian ink, succeeding in finding lymph node stained with methylene blue, involvement of affected lymph node after chemotherapy, involvement of suspected lymph node after chemotherapy. Timepoint: After the intervention in the group that has received chemotherapy and after the completion of chemotherapy in the group that will be received chemotherapy. Method of measurement: details of the lymph nodes will be written on the relevant container after the excision and will be examined by an experienced pathologist, and finally the desired variables will be entered directly in the Data Sheet of SPSS program. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences